Congenital Hypoplastic Anemia Completed Phase 4 Trials for Deferasirox (DB01609)

Also known as: Diamond-Blackfan Anemia / Fanconi's Anemia / Hypoplastic anaemia / Fanconi Anemia / Anemia, Hypoplastic / Congenital hypoplastic anemia / Anemia, Diamond-Blackfan / Hypoplastic anemia / Fanconi Anemias / Hypoplastic Anemias, Congenital / Diamond Blackfan Anemia / Anemia, Diamond Blackfan / Anemia, Hypoplastic, Congenital / Blackfan-Diamond syndrome / Congenital aplastic anaemia / Congenital aplastic anemia / Constitutional aplastic anaemia / Constitutional aplastic anemia / Anaemia hypoplastic / Anemia hypoplastic / Diamond-Blackfan anaemia / Fanconi's anaemia

IndicationStatusPhase
DBCOND0052431 (Congenital Hypoplastic Anemia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00673608Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron OverloadTreatment